Find a Trial
Trial Results
5 protocol(s) meet the specified criteria
ARO-021OPEN TO ACCRUAL
Phase III Randomized Study of Crenolanib versus Midostaurin Administered Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed Subjects with FLT3 Mutated Acute Myeloid Leukemia
CTO-AT148002OPEN TO ACCRUAL
A PHASE 1/2 STUDY OF ALX148 IN COMBINATION WITH AZACITIDINE IN PATIENTS WITH HIGHER RISK MYELODYSPLASTIC SYNDROME (MDS)
CTO-CLR-15-03OPEN TO ACCRUAL
A Two-Part Phase 1/2 Study to Determine Safety, Tolerability, Pharmacokinetics, and Activity of K0706, a Novel Tyrosine Kinase Inhibitor (TKI), in Healthy Subjects and in Subjects with Chronic Myeloid Leukemia (CML) or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
CTO-INCB-50465-304OPEN TO ACCRUAL
A Randomized, Double-Blind, Placebo-Controlled Study of the PI3Kδ Inhibitor Parsaclisib Plus Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib.
CTO-KO-MEN-001OPEN TO ACCRUAL
A Phase 1/2A First in Human Study of the Menin-MLL(KMT2A) Inhibitor
KO-539 in Patients with Relapsed or Refractory Acute Myeloid Leukemia